Peer Review History

Original SubmissionMarch 24, 2026
Decision Letter - Yung-Fu Chang, Editor, Elsio A Wunder Jr, Editor

-->PNTD-D-26-00600

Leptospirosis-Associated Meningitis in an Urban Tropical Endemic Setting in Northeastern Brazil: Three New Cases and a Meta-summary of 176 Reported Cases

PLOS Neglected Tropical Diseases

Dear Dr. Farias,

Thank you for submitting your manuscript to PLOS Neglected Tropical Diseases. After careful consideration, we feel that it has merit but does not fully meet PLOS Neglected Tropical Diseases's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript within by four weeks. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosntds@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pntd/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

* A letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to any formatting updates and technical items listed in the 'Journal Requirements' section below.

* A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

* An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Yung-Fu Chang

Academic Editor

PLOS Neglected Tropical Diseases

Elsio Wunder Jr

Section Editor

PLOS Neglected Tropical Diseases

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-4304-636XX

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-1765-0002

Additional Editor Comments (if provided):

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

[Note: HTML markup is below. Please do not edit.]

Reviewers' Comments:

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: Methods are OK but clarification/further details should be given to what constitutes lab confirmation of a positive leptospirosis case.

Reviewer #2: Well-structured and methodologically thoughtful, especially the integration of clinical cohort and meta-summary. However, why 3 cases chosen must be answered in the background of high volume literature review cases; why not this is a simple case series with review literature rather making cohort + meta-summary? If it cant be justifiled, better manuscript be revised as simple case series with review literaure.

Definitions are appropriate; consider streamlining for readability by reducing repetition and consolidating overlapping criteria. The literature review methodology would benefit from greater rigor/clarity (e.g., search timeframe, selection process, potential bias). Justification for outlier exclusion thresholds is good; can be strengthened by briefly citing or referencing expected biological ranges.

**********

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: Results are appropriate except for the authors' overinterpretation of the infecting serovar from previous publications. Serology CANNOT identify the infecting serovar (multiple publications have proven this) and therefore the table and text need to be revised to reflect this. Additionally, the way that historical publications stated the Leptospira nomenclature is inaccurate. The species should be italicized and the serovar capitalized.

Reviewer #2: Strong descriptive detail and clinically rich cases; consider improving conciseness by focusing on findings most relevant to LAM. Enhance consistency in data reporting (units, structure across cases) to improve readability and comparability. The literature synthesis is valuable; to improve, emphasize key patterns rather than detailed enumeration (e.g., highlight dominant trends over listing serovars). The CSF analysis is a major strength; consider linking findings more explicitly to clinical implications.

**********

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: Conclusions are OK EXCEPT for the assumption that serology can determine the infecting serovar (see above).

Reviewer #2: The conclusion is missing in main text, however in abstract, it is solid but could be sharpened with a clearer clinical or research-oriented closing statement.

**********

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: (No Response)

Reviewer #2: This is a high-quality, well-researched manuscript with strong novelty in combining clinical data and meta-summary.

Key improvements lie in enhancing clarity, reducing density, and emphasizing your unique contribution and clinical relevance. Tightening the narrative will significantly improve readability and publication impact without altering content depth.

**********

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: This is a thorough review of characteristics of aseptic meningitis due to leptospirosis. I think the authors should emphasize strongly that this is likely underreported as a cause of meningitis (the authors have referenced previous studies that looked at PCR diagnosis). The authors also will need to edit the text and table since serology cannot identify the infecting serovar. This was a historic but inaccurate belief, but multiple publications have cautioned that serology cannot identify the infecting serovar.

Reviewer #2: Few points about ABSTRACT: Strong structure and clear integration of cohort + meta-summary; to improve further, clarify the novel contribution more explicitly (e.g., first combined CSF profile synthesis). The results are well presented, but could be strengthened by briefly quantifying key pooled findings (e.g., median CSF values) to increase impact. Conclusion is comprehensive; consider slightly sharpening the clinical takeaway (e.g., when to suspect LAM in practice).

Few remarks on INTRODUCTION: Excellent epidemiological grounding and regional relevance that enhances further by tightening redundancy in pathophysiology description. The knowledge gap is clearly identified; to strengthen it, more explicitly state why prior literature is insufficient (methodological limitations, heterogeneity). The final paragraph is strong but could benefit from a more concise and focused study aim statement.

Similarly DISCUSSION: Highly comprehensive and intellectually strong, particularly in pathophysiology and literature integration. To improve, enhance focus and prioritization, the discussion is dense and would benefit from clearer highlighting of the most important insights. Strengthen direct linkage to your findings (cohort + meta-summary) rather than extended general literature exposition. Some historical and mechanistic details, while interesting, could be condensed to maintain narrative clarity and impact.

The limitations section is appropriate; consider making it slightly more explicit and structured

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: prasan kumar panda

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

Figure resubmission:

>While revising your submission, we strongly recommend that you use PLOS’s NAAS tool (https://ngplosjournals.pagemajik.ai/artanalysis) to test your figure files. NAAS can convert your figure files to the TIFF file type and meet basic requirements (such as print size, resolution), or provide you with a report on issues that do not meet our requirements and that NAAS cannot fix.--> -->

After uploading your figures to PLOS’s NAAS tool - https://ngplosjournals.pagemajik.ai/artanalysis, NAAS will process the files provided and display the results in the "Uploaded Files" section of the page as the processing is complete. If the uploaded figures meet our requirements (or NAAS is able to fix the files to meet our requirements), the figure will be marked as "fixed" above. If NAAS is unable to fix the files, a red "failed" label will appear above. When NAAS has confirmed that the figure files meet our requirements, please download the file via the download option, and include these NAAS processed figure files when submitting your revised manuscript.-->

Reproducibility:

To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

-->

Attachments
Attachment
Submitted filename: PNTD-D-26-00600_reviewer (1) RG.pdf
Revision 1

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Yung-Fu Chang, Editor, Elsio A Wunder Jr, Editor

Dear Farias,

We are pleased to inform you that your manuscript 'Leptospirosis-Associated Meningitis in an Urban Tropical Endemic Setting in Northeastern Brazil: Three New Cases and a Meta-summary of 176 Reported Cases' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Yung-Fu Chang

Academic Editor

PLOS Neglected Tropical Diseases

Elsio Wunder Jr

Section Editor

PLOS Neglected Tropical Diseases

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-4304-636XX

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-1765-0002

***********************************************************

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; line-height: 16.0px; font: 14.0px Arial; color: #323333; -webkit-text-stroke: #323333}span.s1 {font-kerning: none

Formally Accepted
Acceptance Letter - Yung-Fu Chang, Editor, Elsio A Wunder Jr, Editor

Dear Mr. Gadelha Farias,

We are delighted to inform you that your manuscript, "Leptospirosis-Associated Meningitis in an Urban Tropical Endemic Setting in Northeastern Brazil: Three New Cases and a Meta-summary of 176 Reported Cases," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

For Research Articles, you will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .